Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Data-Only Studies
Biospecimen Studies
Results: 1733 (Showing 1 to 20)
Name Principal Investigator Institution Study Date Approved Project ID
Machine learning to differentiate between malignant and benign nodules Parag Chaudhari Mon Health Medical Center NLST Nov 17, 2020 NLST-315
Applying Machine Learning on available datasets to derive knowledge Shalini Madhan st josephs college of engineering PLCO Nov 17, 2020 PLCO-690
An examination of the relationship between specific driver mutations, target drugs, and immunotherapies in non-small cell lung cancer survival outcomes. Lauren Connell Independent PLCO Nov 17, 2020 PLCO-691
Inflammatory potential of diet and survival of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Zhuyue Li Sichuan University PLCO Oct 27, 2020 PLCO-682
Evaluating key determinants for the risk of second primary lung cancer among breast and colorectal cancer survivors using population-based screening trial data from the PLCO Summer Han Stanford University PLCO Oct 27, 2020 PLCO-683
Statistical Methods and Artificial Intelligence Deep Learning to Identify the Risk Factors of Colorectal Cancer Ranju Karki University of South Florida PLCO Oct 27, 2020 PLCO-684
Validation of Deep Learning Algorithm by using extended follow-up data in the National Lung Screening Trial Ping Hu NCI NLST Oct 22, 2020 NLST-715
Statistical Modelling on Pancreatic Cancer ADITYA CHAKRABORTY University of south Florida PLCO Oct 22, 2020 PLCO-680
Statistical methods to identify the “causal SNP” from among SNPs in high LD with an index SNP Mitchell Gail National Cancer Institute PLCO Oct 22, 2020 PLCO-678
Predicting time to castration resistance in hormone sensitive prostate cancer Ari Robinson The Institute for Medical BioMathematics (IMBM) PLCO Oct 22, 2020 PLCO-677
Development and cost analysis of a lung nodule management strategy combining artificial intelligence and Lung-RADS for baseline lung cancer screening Paul Babyn University of Saskatchewan NLST Oct 22, 2020 NLST-722
Detection of pulmonary nodules Yubo Liu Qingdao University of Science and Technology NLST Oct 19, 2020 NLST-719
Explainable Artificial Intelligence in Radiotherapy: A CT imaging based neural network autonomous system for clinical decision support used in automatic radiation dose calculation for Lung Carcinoma (Lung Cancer) Hristo Petkov University Of Strathclyde NLST Oct 17, 2020 NLST-720
Reconstructing volumetric Computed Tomography data from 2D X-ray projections with deep learning Tianyu Han Physics of Molecular Imaging Systems, Experimental Molecular Imaging, RWTH Aachen University NLST Oct 13, 2020 NLST-717
Detection of Second Primary Lung Cancer After Head and Neck Cancer with or without Screening John Cramer Karmanos Cancer Institute PLCO Oct 8, 2020 PLCO-669
Assessing the Risk and Cost of the Digital Rectal Exam: Is It Time to Abandon the DRE? Sanoj Punnen University of Miami Miller School of Medicine PLCO Oct 8, 2020 PLCO-671
Vitamin K intake and pancreatic cancer incidence and death in the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial Guo-Chao Zhong Chongqing Medical University PLCO Oct 8, 2020 PLCO-672
Biological bases of lung cancer risk disparities for African American male smokers Chengguo Xing University of Florida PLCO Oct 8, 2020 PLCO-673
Incidence of Second Primary Lung Cancer in Patients with a History of Head and Neck Cancer John Cramer Karmanos Cancer Institute NLST Oct 8, 2020 NLST-714
lung cancer screening anwei li shiyuan health research center NLST Oct 8, 2020 NLST-713